1. Home
  2. KMX vs PTGX Comparison

KMX vs PTGX Comparison

Compare KMX & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarMax Inc

KMX

CarMax Inc

HOLD

Current Price

$48.60

Market Cap

5.6B

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$82.58

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMX
PTGX
Founded
1993
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.4B
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
KMX
PTGX
Price
$48.60
$82.58
Analyst Decision
Hold
Strong Buy
Analyst Count
17
9
Target Price
$40.58
$93.00
AVG Volume (30 Days)
4.6M
863.4K
Earning Date
12-18-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
3.67
N/A
EPS
3.04
0.72
Revenue
$27,834,194,000.00
$209,217,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.99
$288.98
P/E Ratio
$15.95
$117.67
Revenue Growth
0.14
N/A
52 Week Low
$30.26
$33.70
52 Week High
$89.47
$96.54

Technical Indicators

Market Signals
Indicator
KMX
PTGX
Relative Strength Index (RSI) 78.84 43.54
Support Level $44.04 $78.75
Resistance Level $48.83 $87.44
Average True Range (ATR) 1.71 3.01
MACD 0.83 -0.27
Stochastic Oscillator 97.50 36.81

Price Performance

Historical Comparison
KMX
PTGX

About KMX CarMax Inc

CarMax sells, finances, and services used and new cars through a chain of over 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: